Training student pharmacists to administer long-acting injectable medications [0.03%]
住院药学研究生长效注射剂给药培训项目
Megan J Ehret,Raymond C Love,Bethany DiPaula
Megan J Ehret
Objective/process: In June of 2022, the State of Maryland Board of Pharmacy issued regulations permitting pharmacist administration of maintenance injectable medications. Subsequently, the University of Maryland School of...
Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients [0.03%]
长效抗精神病注射药物与口服抗精神病药在儿童患者中的住院再入院率比较研究
Danial Chowdhury,Daniel Greer,Mei T Liu et al.
Danial Chowdhury et al.
Introduction: Studies indicate that long-acting injectable antipsychotics (LAIAs) reduce the risk of relapse and hospitalization compared with oral antipsychotics (APs) in adults. Oral formulations of APs are well-studied...
Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications [0.03%]
口服纳曲酮治疗期间尿液毒品筛查出阿片类阳性及其临床意义
Elena R Beauregard,Elizabeth G Maguire
Elena R Beauregard
Introduction: Naltrexone is an opioid antagonist that is FDA approved to treat alcohol dependence and opioid dependence. It is available as an oral tablet and an extended-release injectable suspension. Naltrexone is metab...
Amy VandenBerg,Erica A K Davis
Amy VandenBerg
Brooke Gessner,Michelle Carter,Kiana Rahnama et al.
Brooke Gessner et al.
Introduction: Clozapine is the most effective antipsychotic in the management of treatment-resistant schizophrenia; however, its use is challenging due to the risk of severe adverse effects. Despite the risks associated w...
Differences in serum concentration with valproate oral solution versus delayed-release divalproex in an adherent patient [0.03%]
服用丙戊酸口服液和缓释双丙戊酸钠片的血药浓度比较（依从性好的患者）
Erica A K Davis
Erica A K Davis
Background: Several different formulations of valproic acid derivatives are available in the United States. Although these formulations have different absorption characteristics, they are believed to be interchangeable, w...
Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns [0.03%]
抗精神病药在儿童和青少年抑郁症患者中的应用：药物使用模式的回顾性分析
Danielle Dauchot,Suzanne Rettey,Brittany L Melton et al.
Danielle Dauchot et al.
Introduction: Depression rates in children/adolescents in the United States have increased in the last 10 years. Fluoxetine and escitalopram are the only 2 antidepressants approved for the treatment of major depression di...
Jessica L Ho,Jenna Roberts,Gregory H Payne et al.
Jessica L Ho et al.
Introduction: Pharmacists focusing on psychotropic medication management and practicing across a wide variety of healthcare settings have significantly improved patient-level outcomes. The Systematic Literature Review Com...
Shawn R Smith,Leslie Banuelos,Nalea Trujillo et al.
Shawn R Smith et al.
Introduction: Adverse childhood experiences (ACEs) are associated with higher mental and physical illness and substance use disorders in adulthood. However, little is known about the prevalence of ACEs among student pharm...
Clinical pharmacist intervention to ensure safe stimulant prescribing practices at a Veterans Affairs facility [0.03%]
临床药剂师干预以确保退伍军人事务设施中的安全刺激剂处方实践
Bailey B Bass,Lacey J Vann
Bailey B Bass
Introduction: The Psychotropic Drug Safety Initiative (PDSI) is a national Veterans Affairs program that recommends obtaining cardiovascular vital signs semiannually and urine toxicology screening annually for veterans pr...